Skip to content
WorldBrand.AI

W. L. Gore & Associates

Corporate brand

UnclaimedRequest correction

W. L. Gore & Associates is a privately held American materials-science company whose portfolio spans medical devices, high-performance fabrics, electronics, industrial filtration, aerospace technologies, energy systems and specialty consumer products.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

W. L. Gore & Associates is a privately held American materials-science company headquartered in Newark, Delaware. Founded on January 1, 1958, by former DuPont researcher Wilbert L. “Bill” Gore and his wife, Genevieve “Vieve” Gore, the enterprise began in the basement of the Gores’ home with a practical objective: to exploit the unusual electrical-insulation properties of polytetrafluoroethylene, or PTFE. Its first commercial product, MULTI-TET insulated wire and cable, was developed for demanding applications in computing, communications, process control and aerospace. The company’s defining technical breakthrough came in 1969, when Bill Gore’s son Robert W. “Bob” Gore discovered that PTFE could be rapidly stretched into a microporous material. The resulting expanded PTFE, or ePTFE, combined chemical resistance, thermal stability, low friction, electrical insulation and controlled porosity with a broader range of useful mechanical properties. That discovery became the foundation for much of Gore’s later portfolio. It enabled high-performance cables, filtration media, medical implants, seals, membranes, fibers, vents, surgical materials and the waterproof-breathable membrane eventually commercialized under the GORE-TEX brand. Gore is best known publicly for GORE-TEX products, which helped establish waterproof-breathable technical apparel and footwear as a major outdoor category. The company made its first GORE-TEX fabric sale in 1976 to Early Winters, an outdoor-equipment company. The brand subsequently expanded from rainwear into footwear, gloves, military apparel, protective clothing and other performance applications. Gore’s fabric business has increasingly emphasized membranes based on expanded polyethylene, or ePE, while continuing to position the brand around durability, weather protection and performance in demanding environments. Medical technology is another central business. Gore commercialized its first GORE-TEX vascular graft in 1975, launching a medical-products operation that later expanded into vascular grafts, endovascular stent-grafts, interventional devices, surgical meshes, sutures, cardiovascular patches and other implantable materials. The company states that more than 55 million Gore medical devices have been implanted worldwide. Its medical activities include both branded medical products and original-equipment-manufacturer components used in healthcare devices. Beyond fabrics and healthcare, Gore supplies specialized products for aerospace and defense, telecommunications, automotive systems, semiconductor manufacturing, industrial filtration, pharmaceutical and biopharmaceutical processing, hydrogen and fuel-cell systems, and other high-performance markets. Its technologies have been used in spaceflight hardware, satellite and spacecraft cabling, the Hubble Space Telescope, Mars missions, automotive vents, aircraft communications, industrial dust filtration and fuel-cell membrane assemblies. The company also owns or operates specialty brands and product lines including ELIXIR Strings, GOREWEAR, SITKA Gear and multiple Gore Medical and GORE-TEX businesses. Gore’s organizational culture is unusually important to its brand identity. Bill Gore developed a “lattice” model intended to replace rigid managerial hierarchies with direct communication, peer accountability, self-committed responsibilities and emergent leadership. Gore commonly refers to employees as “Associates,” and its operating philosophy has emphasized freedom, fairness, commitment and consultation before actions that could materially damage the company—the so-called “waterline” principle. In later terminology, the approach has been described as open allocation. The culture has been discussed in management literature and helped make Gore a frequently cited example of a decentralized, team-based enterprise. The company remains privately held and internationally active, with approximately 13,000 Associates and operations in more than two do…

History

W. L. Gore & Associates traces its origins to January 1, 1958, when Wilbert L. “Bill” Gore and Genevieve “Vieve” Gore began operating from the basement of their home in Newark, Delaware. Bill Gore had spent many years at DuPont, including work connected with fluoropolymers, and believed that PTFE could support a wider range of commercial applications than were then available. The new company’s initial task was to solve electrical-insulation problems by using PTFE to protect multiple parallel conductors. The first significant product was MULTI-TET insulated wire and cable. Robert W. “Bob” Gore, Bill and Vieve’s son, helped develop the multiconductor ribbon-cable concept while still in college. The product became important in computing, communications, process control and aerospace. Gore received its first patent in 1963 for the multiconductor wiring strip. Its early customer-driven approach—developing customized solutions for difficult engineering problems—became a recurring pattern in the company’s later growth. Gore products entered the space sector in 1960 through use on the Telstar satellite. In 1969, Bob Gore made the company’s pivotal materials discovery. While experimenting with PTFE, he unexpectedly found that a rapid, accelerating stretch could expand the solid polymer into a porous structure. The material, later known as expanded PTFE or ePTFE, was lightweight, chemically resistant, thermally stable and capable of combining permeability with water resistance. The discovery provided a common technological platform for a wide range of products and changed the scale of Gore’s opportunity. The 1970s marked the beginning of several major businesses. Gore introduced high-speed coaxial cables using ePTFE in 1970 and began industrial filtration activities in 1973. In 1975, the company commercialized its first GORE-TEX Vascular Graft, establishing the medical-products business. In 1976, Gore made its first sale of GORE-TEX fabric to Early Winters, whose catalog helped introduce waterproof-breathable rainwear to outdoor consumers. These developments established the three areas for which Gore became especially recognized: advanced electronics, medical devices and performance fabrics. During the 1980s, Gore broadened the use of ePTFE in healthcare and protective materials. It introduced GORE-TEX Cardiovascular Patch and later GORE-TEX Sutures, while also supplying membranes for firefighting protective clothing. Gore fibers were used in spacesuits for NASA’s first Space Shuttle mission, and military orders helped expand the protective-fabrics business. The company’s medical work increasingly focused on the compatibility of engineered fluoropolymer structures with human tissue and on applications where flexible, durable and biologically compatible materials could support repair or replacement of damaged anatomy. The 1990s brought further diversification. Gore developed automotive vents, fuel-cell membrane electrode assemblies, specialized cables for the Hubble Space Telescope and products for other aerospace systems. In 1997 it introduced ELIXIR Strings, a specialty consumer line that applied a thin protective coating to guitar strings. The same period saw Gore introduce minimally invasive endovascular prostheses combining ePTFE graft materials with Nitinol stents. This helped move the medical business beyond conventional grafts toward catheter-delivered vascular repair. In the 2000s, Gore technologies supported NASA’s Mars missions, the Hubble program and the retractable roof at Wimbledon’s Centre Court. Gore also expanded cardiovascular products, including the GORE HELEX Septal Occluder, which was launched in multiple international markets in 2001. Its products increasingly served pharmaceutical processing, acoustic protection, filtration, telecommunications, automotive and industrial applications. The company’s technology strategy remained platform-based: develop a material structure or manufacturing capability, then adapt it to a new environment or customer problem. Gore’s internal organization developed in parallel with its technical portfolio. Bill Gore drew on his DuPont experience with temporary, multidisciplinary task forces and proposed a lattice organization in which Associates communicated directly rather than through a fixed chain of command. Gore’s culture principles emphasized freedom, fairness, commitment and consultation in situations that might affect the company’s “waterline.” The model encouraged teams to form around opportunities, allowed leaders to emerge through followership and reduced reliance on conventional managerial hierarchy. The culture became a major element of Gore’s reputation and was discussed in books on organizational design and workplace innovation. Leadership transitioned through several generations. Robert Gore was followed as president by Charles Carroll in 2000, Terri Kelly in 2005, Jason Field in 2018 and Bret Snyder in 2020. Snyder, a grandson of the founders, became president and CEO while retaining the board-chair role. The company remained privately held throughout these changes. In the 2010s and 2020s, Gore continued to pursue advanced applications while facing greater public scrutiny. Regulators investigated allegations that its commercial practices limited competition in waterproof-breathable membranes. Separate litigation later alleged that historical PFAS-related manufacturing practices caused environmental contamination and harm to employees or residents; Gore has denied or disputed the allegations. At the same time, Gore introduced next-generation GORE-TEX products using an ePE membrane, promoted materials-stewardship initiatives and reorganized parts of its business around Medical, Performance Solutions, Fabrics and Specialty activities. Recent developments include synthetic-cornea research, battery technology work and the 2026 acquisition of Conformal Medical, which added an investigational left atrial appendage closure technology to Gore’s endovascular portfolio.

  • 2026

    Conformal Medical acquisition completed

    [7]

    Gore completes the acquisition of Conformal Medical, adding investigational CLAAS AcuFORM left atrial appendage occlusion technology to its cardiac portfolio.

  • 2024

    Investigational synthetic-cornea implants

    [1]

    Gore reports first human implants of an investigational synthetic cornea in a pilot study in Mexico City.

  • 2022

    Next-generation GORE-TEX products with ePE membrane

    [1]

    Gore launches its first GORE-TEX products using an expanded polyethylene membrane.

  • 2020

    Bret Snyder becomes president and CEO

    [5]

    Bret Snyder succeeds Jason Field as president and CEO while continuing as board chair.

  • 2018

    GORE ImproJect Plunger introduced

    [1]

    Gore unveils a silicone-free plunger system for delivery of sensitive biologics.

  • 2016

    Gravitational-wave detection cable contribution

    [1]

    Gore High Flex Planar Cables support instruments used by astrophysicists in gravitational-wave research.

  • 2008

    Mars Phoenix Lander cable contribution

    [1]

    Gore spaceflight microwave cable assemblies help transmit data used during the Phoenix lander’s arrival on Mars.

  • 2004

    Mars rover communications support

    [1]

    Gore microwave cable assemblies support communications and image transmission for NASA’s Spirit and Opportunity spacecraft.

  • 2001

    GORE HELEX Septal Occluder launches internationally

    [1]

    The GORE HELEX Septal Occluder launches in Europe, Africa, Australia and South America for treatment of congenital heart defects.

  • 1997

    ELIXIR Strings and minimally invasive endovascular technology

    [1]

    Gore introduces ELIXIR coated guitar strings and its first minimally invasive endovascular prosthesis combining ePTFE grafts with Nitinol stents.

Products and positioning

A science-led, privately held materials-innovation enterprise that applies fluoropolymer expertise and decentralized product-development teams to demanding applications where reliability, durability, biocompatibility, contamination control or environmental resistance are critical.

  • Performance fabrics · 1976

    GORE-TEX Products

    GORE-TEX products are waterproof-breathable membrane systems used in outdoor apparel, footwear, gloves, professional protective clothing and other applications. The brand was built around microporous fluoropolymer membranes that block liquid water while permitting water vapor to pass through. Gore has also introduced newer ePE-membrane products as part of its materials-stewardship and product-evolution strategy. Products are generally made through partnerships with licensed manufacturers rather than sold exclusively as finished Gore-branded apparel.

  • Medical devices · 1975

    Gore Medical vascular and endovascular devices

    Gore Medical develops implantable devices for vascular, endovascular and interventional procedures. The portfolio includes synthetic vascular grafts, endovascular stent-grafts, peripheral and aortic devices, cardiac interventions and other catheter-delivered technologies. Gore’s medical approach uses engineered fluoropolymer structures and other materials designed to interact with tissue, restore blood flow or reinforce diseased anatomy while supporting less invasive procedures.

  • Surgical materials · 1981

    GORE-TEX Sutures and Cardiovascular Patches

    These ePTFE-based surgical products are used in vascular, cardiac and general surgical procedures. Cardiovascular patches provide sheet material for repairing or reinforcing tissue, while GORE-TEX Sutures are designed to provide predictable handling and performance in selected surgical specialties. The products illustrate Gore’s use of expanded PTFE beyond membranes and apparel, particularly where flexibility, durability and biocompatibility are important.

  • Endovascular devices · 1997

    GORE EXCLUDER and other endovascular prostheses

    Gore’s endovascular prostheses combine fabric graft structures with stent frameworks to re-line or exclude diseased portions of blood vessels. The category grew from Gore’s first minimally invasive endovascular prosthesis in 1997 and includes devices used in complex aortic and peripheral interventions. Product availability and indications vary by market and regulatory authorization.

  • Musical instrument strings · 1997

    ELIXIR Strings

    ELIXIR Strings are coated acoustic, electric and bass guitar strings developed from Gore’s fluoropolymer and cable-engineering expertise. The coating forms a barrier over the string and between the windings, helping reduce the accumulation of dirt, sweat and corrosive contaminants. POLYWEB, NANOWEB and OPTIWEB coatings provide different combinations of tone and feel. The line began after Gore engineers used guitar strings as test materials while developing smoother push-pull cables.

  • Electronics and communications · 1958

    Gore electronic cables and signal-transmission products

    Gore supplies insulated wire, ribbon cables, coaxial cables, microwave cable assemblies, high-flex planar cables, cable-based antennas and related signal-transmission products. These products are designed for aerospace, defense, telecommunications, computing, mobile electronics and other environments where low signal loss, mechanical flexibility, thermal stability and long-term reliability are important.

  • Industrial materials · 1973

    Gore industrial filtration and venting products

    Gore’s industrial portfolio includes ePTFE filter bags, membrane filtration products, automotive vents, acoustic vents and protective venting systems. These products allow air, gases or pressure to move while resisting liquid water, oils, particles or other contaminants. Applications include industrial emissions control, automotive components, electronics, batteries, appliances, pharmaceutical processing and equipment protection.

  • Clean energy materials · 1995

    Gore fuel-cell and hydrogen technologies

    Gore develops membrane electrode assemblies and related materials for fuel-cell and hydrogen applications. These technologies use engineered membranes and catalysts to support electrochemical energy conversion. The business extends Gore’s platform-materials approach into automotive, stationary-power and other clean-energy markets where chemical stability, conductivity, durability and process consistency are important.

  • Investigational cardiovascular device · 2026

    CLAAS AcuFORM System

    The CLAAS AcuFORM System is an investigational left atrial appendage occlusion technology developed by Conformal Medical and acquired by Gore in 2026. It uses a nitinol endoskeleton and proprietary foam matrix intended to conform to a broader range of left atrial appendage anatomies with fewer device sizes. At the time of the acquisition announcement, it remained in clinical testing and was not approved for commercial use.

Controversies

  • 2025

    PFAS and GORE-TEX marketing litigation

    Consumer litigation alleged that certain GORE-TEX marketing and product claims were misleading in light of the use of PFAS-related chemistry and the environmental and health concerns associated with some PFAS compounds. These are allegations in pending or reported litigation, not established findings of fact.

    Source

  • 2024

    Maryland PFAS contamination lawsuit

    The Maryland Attorney General sued Gore in federal court, alleging decades of releases of PFAS chemicals from Cecil County facilities and seeking remedies related to environmental contamination and public health. The allegations remain subject to litigation, and Gore has denied them.

    Source

  • 2022

    PFAS-related employee and community litigation

    A former employee and residents near Gore’s Cherry Hill facility in Maryland brought claims alleging that historical PFAS-related manufacturing practices caused exposure, environmental contamination and health effects. Gore has disputed the allegations.

    Source

  • 2011

    Federal Trade Commission competition investigation

    The Federal Trade Commission authorized compulsory process in a nonpublic investigation into whether Gore used contracts, exclusionary practices or other conduct relating to waterproof and waterproof-breathable membranes in ways that could violate the Federal Trade Commission Act. The existence of an investigation does not itself establish liability.

    Source

Read more

Marketing campaigns

  • 2022Next-generation GORE-TEX with ePE membrane

    International

    Gore introduced GORE-TEX products using an expanded polyethylene membrane and presented the move as part of a responsible-performance journey. The product communication emphasized durable performance, long product life and a transition toward newer membrane chemistry.

    Outcome. Created a new generation of GORE-TEX products and gave the fabrics business a response to growing scrutiny of legacy fluoropolymer chemistry.

    Source
  • 2016ELIXIR OPTIWEB electric-string launch campaign

    International

    ELIXIR Strings introduced OPTIWEB coating for electric guitar strings with a globally supported consumer campaign intended to encourage awareness, trial and comparison with uncoated electric strings. The launch used product demonstrations and differentiated the coating family by tone and feel.

    Outcome. Expanded ELIXIR’s electric-string range and positioned POLYWEB, NANOWEB and OPTIWEB as coating options for distinct playing preferences.

    Source
  • 1990GORE-TEX Antarctica performance demonstration

    International · Antarctica

    An international team traversing Antarctica wore GORE-TEX outerwear, providing a high-visibility demonstration of the fabric’s use in severe cold, wind and precipitation. Gore used demanding-environment performance as a central proof point for the brand.

    Outcome. Strengthened the association between GORE-TEX and extreme-environment reliability.

    Source
  • 1976Early Winters GORE-TEX Rainwear introduction

    United States

    Gore’s first sale of GORE-TEX fabric was made to Early Winters, whose catalog presented the material in technical outdoor rainwear. The launch translated Gore’s membrane technology from an industrial material into a consumer-facing performance proposition centered on waterproof protection and breathability.

    Outcome. Helped establish GORE-TEX as a recognizable outdoor-performance brand and created a platform for later apparel, footwear and protective-clothing licensing.

    Source

Brand decisions

  • 2026

    Acquire Conformal MedicalM&A

    Background

    Gore identified Conformal Medical’s investigational CLAAS AcuFORM system as complementary to its existing cardiac and endovascular portfolio.

    Action taken

    Entered into and subsequently completed an acquisition of Conformal Medical, adding its investigational left atrial appendage occlusion technology.

    Aftermath

    The transaction expanded Gore’s endovascular development pipeline and added a clinical-stage cardiac technology that remained subject to regulatory and commercialization requirements.

    Source

  • 2023

    Reorganize business activities into four groupsStrategy

    Background

    Gore historically organized around Medical, Performance Solutions and Fabrics divisions, but sought to simplify collaboration and embed core technology and support capabilities more directly into business groups.

    Action taken

    Began shifting toward four groups: Medical, Performance Solutions, Fabrics and Specialty.

    Aftermath

    The revised structure was intended to improve innovation coordination across clean energy, pharmaceutical processing, life sciences and consumer-string activities while retaining the company’s technology-platform approach.

    Source

  • 2022

    Introduce ePE-based GORE-TEX productsGeneration change

    Background

    The fabrics business faced increasing demand for durable performance products with a lower-impact materials profile and greater attention to PFAS-related chemistry.

    Action taken

    Launched the first GORE-TEX products using an expanded polyethylene membrane.

    Aftermath

    The move created a next-generation product platform while preserving the GORE-TEX brand’s central waterproof-breathable performance proposition.

    Source

  • 2020

    Maintain private, decentralized leadership model under a new CEOStrategy

    Background

    Gore’s leadership succession occurred within a privately held enterprise whose culture emphasizes direct communication, peer accountability and emergent leadership rather than conventional hierarchy.

    Action taken

    Appointed Bret Snyder president and CEO while retaining him as chair of the board, following Jason Field’s tenure.

    Aftermath

    The change continued multigenerational family involvement in company leadership while preserving Gore’s established operating model.

    Source

  • 1997

    Shift toward minimally invasive endovascular repairGeneration change

    Background

    Advances in catheter delivery, stent structures and vascular graft materials created an opportunity to treat diseased vessels without conventional open surgery in every case.

    Action taken

    Introduced a minimally invasive endovascular prosthesis combining ePTFE graft material with Nitinol stents.

    Aftermath

    The move broadened Gore Medical from surgical grafts into catheter-based vascular intervention and became a foundation for later endovascular product families.

    Source

  • 1997

    Launch ELIXIR StringsProduct launch

    Background

    Gore engineers discovered that guitar strings could serve as thin, strong test articles during development of smoother push-pull cables. Further experimentation suggested that a protective coating could extend string life without unacceptable effects on tone.

    Action taken

    Introduced ELIXIR Strings with a full-string protective coating and later expanded the line into different coating technologies and instrument categories.

    Aftermath

    ELIXIR became a significant specialty consumer product line and extended Gore’s materials expertise into the musical-instrument market.

    Source

  • 1975

    Enter the medical-device market with GORE-TEX Vascular GraftProduct launch

    Background

    Gore’s ePTFE material offered a route into implantable vascular products because it could be engineered into durable, flexible structures suitable for demanding biological environments.

    Action taken

    Commercialized the first GORE-TEX Vascular Graft in the United States, establishing a dedicated medical-products business.

    Aftermath

    Medical became one of Gore’s core businesses and later expanded into endovascular, interventional, cardiac and surgical products.

    Source

Recent events

  • 2026

    Gore announced an agreement to acquire Conformal Medical[6]

    M&A · Product launch

    Gore agreed to acquire Conformal Medical and its investigational CLAAS AcuFORM left atrial appendage occlusion system, expanding Gore’s endovascular and cardiac portfolio. The transaction was described as subject to regulatory approval at announcement.

  • 2026

    Gore completed its acquisition of Conformal Medical[7]

    M&A · Leadership change

    Gore reported completion of the Conformal Medical acquisition, adding the investigational CLAAS AcuFORM technology to its cardiac and endovascular activities.

  • 2025

    Gore introduced its Shanghai battery laboratory[7]

    Product launch

    Gore announced a Shanghai laboratory intended to accelerate research and collaboration in battery technology, reflecting continued expansion of its specialty and clean-energy activities.

  • 2022

    Gore announced a next-generation GORE-TEX membrane based on ePE[1]

    Product launch · Product generation

    Gore launched its first GORE-TEX products using an expanded polyethylene membrane, presenting the change as part of a responsible-performance strategy for durable waterproof-breathable products.

  • 2020

    Bret Snyder became president and CEO[5]

    Leadership change

    Bret Snyder succeeded Jason Field as president and CEO while retaining the chair role. Snyder is a grandson of founders Bill and Vieve Gore and had held technical and leadership roles at Gore since joining in 2008.

  • 2018

    Jason Field succeeded Terri Kelly as president and CEO[17]

    Leadership change

    Jason Field, previously a global sales and marketing leader in Gore Medical, succeeded Terri Kelly as president and CEO.

Sources19 sources

  1. 1Our Historygore.com
  2. 2About Goregore.com
  3. 3Medical Productsgore.com
  4. 4The Gore Storygore.com
  5. 5Bret Snyder Named President & Chief Executive Officer of W. L. Gore & Associatesgore.com
  6. 6W. L. Gore & Associates to Acquire Conformal Medicalgore.com
  7. 7W. L. Gore & Associates Completes Acquisition of Conformal Medicalgore.com
  8. 8Federal Trade Commission W. L. Gore & Associates matterftc.gov
  9. 9Maryland complaint against W. L. Gore & Associatesoag.maryland.gov
  10. 10ELIXIR Strings company historyglobal.elixirstrings.com
  11. 11Gore 2023 Executive Summarygore.com
  12. 12W. L. Gore & Associates Wikipedia articleen.wikipedia.org
  13. 13First GORE-TEX Vascular Graft commercializedgore.com
  14. 14ELIXIR OPTIWEB electric-string launch campaignglobal.elixirstrings.com
  15. 15PFAS-related employee and community litigationgoreclassaction.com
  16. 16PFAS and GORE-TEX marketing litigationhbsslaw.com
  17. 17Jason Field succeeded Terri Kelly as president and CEOkr.gore.com
  18. 18Gore Launches New Online Microwave/RF Assembly Builderprweb.com
  19. 19W. L. Gore & Associates Launches GORE® Battery Vents – MultiVent Series at the Battery Showtimminspress.com

Cite this profile: Cite the canonical profile. /brand-wiki/w-l-gore-and-associates · Editorial policy · How profiles are compiled